Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-15

Clinical Trial Update: Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating riluzole for obsessive-compulsive disorder in children and adolescents, with or without autism spectrum disorders, has completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Obsessive-Compulsive Disorder, Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-07-15